{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:44:34Z","timestamp":1791229474115,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Shanghai Municipal Huangpu District Commission","award":["HLQ202004"],"award-info":[{"award-number":["HLQ202004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s42000-022-00374-x","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T19:02:30Z","timestamp":1653159750000},"page":"437-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of hypertriglyceridemic waist phenotype with non-alcoholic fatty liver disease: a cross-sectional study in a Chinese population"],"prefix":"10.1007","volume":"21","author":[{"given":"Yan","family":"Xuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dou","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FanFan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiqun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3500-176X","authenticated-orcid":false,"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,21]]},"reference":[{"issue":"4","key":"374_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","volume":"70","author":"F Zhou","year":"2019","unstructured":"Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H (2019) Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatol 70(4):1119\u20131133. https:\/\/doi.org\/10.1002\/hep.30702","journal-title":"Hepatol"},{"issue":"4","key":"374_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day CP, Eguchi Y, Geier A, Kondili LA, Kroy DC, Lazarus JV, Loomba R, Manns MP, Marchesini G, Nakajima A, Negro F, Petta S, Ratziu V, Romero-Gomez M, Sanyal A, Schattenberg JM, Tacke F, Tanaka J, Trautwein C, Wei L, Zeuzem S, Razavi H (2018) Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol 69(4):896\u2013904. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036","journal-title":"J Hepatol"},{"issue":"40","key":"374_CR3","doi-asserted-by":"publisher","first-page":"e1682","DOI":"10.1097\/MD.0000000000001682","volume":"94","author":"X Huang","year":"2015","unstructured":"Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, Ding L, Lin L, Xu Y, Chen Y, Lu J, Wang W, Bi Y, Ning G (2015) Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine (Baltimore) 94(40):e1682. https:\/\/doi.org\/10.1097\/MD.0000000000001682","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"374_CR4","doi-asserted-by":"publisher","first-page":"e3957","DOI":"10.1210\/clinem\/dgab425","volume":"106","author":"G Zuo","year":"2021","unstructured":"Zuo G, Xuan L, Xin Z, Xu Y, Lu J, Chen Y, Dai M, Zhang D, Wang W, Li M, Bi Y, Ning G, Xu M (2021) New nonalcoholic fatty liver disease and fibrosis progression associate with the risk of incident chronic kidney disease. J Clin Endocrinol Metab 106(10):e3957\u2013e3968. https:\/\/doi.org\/10.1210\/clinem\/dgab425","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"374_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1055\/s-0043-100019","volume":"67","author":"Y Panahi","year":"2017","unstructured":"Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendia LE, Sahebkar A (2017) Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial. Drug Res (Stuttg) 67(4):244\u2013251. https:\/\/doi.org\/10.1055\/s-0043-100019","journal-title":"Drug Res (Stuttg)"},{"issue":"7","key":"374_CR6","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"G Musso","year":"2014","unstructured":"Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, Hultcrantz R, Hagstrom H, Yoon SK, Charatcharoenwitthaya P, George J, Barrera F, Hafliethadottir S, Bjornsson ES, Armstrong MJ, Hopkins LJ, Gao X, Francque S, Verrijken A, Yilmaz Y, Lindor KD, Charlton M, Haring R, Lerch MM, Rettig R, Volzke H, Ryu S, Li G, Wong LL, Machado M, Cortez-Pinto H, Yasui K, Cassader M (2014) Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med 11(7):e1001680. https:\/\/doi.org\/10.1371\/journal.pmed.1001680","journal-title":"PLoS Med"},{"issue":"5","key":"374_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/obr.12020","volume":"14","author":"G Musso","year":"2013","unstructured":"Musso G, Cassader M, Olivetti C, Rosina F, Carbone G, Gambino R (2013) Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. Obes Rev 14(5):417\u201331. https:\/\/doi.org\/10.1111\/obr.12020","journal-title":"Obes Rev"},{"key":"374_CR8","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince A, Haas JT, Staels B (2020) Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab 42:101092. https:\/\/doi.org\/10.1016\/j.molmet.2020.101092","journal-title":"Mol Metab"},{"issue":"8","key":"374_CR9","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41366-018-0212-0","volume":"43","author":"H Lee","year":"2019","unstructured":"Lee H, Ahn J, Shin SS, Yoon M (2019) Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor alpha in high-fat-diet-fed C57BL\/6J mice. Int J Obes (Lond) 43(8):1620\u20131630. https:\/\/doi.org\/10.1038\/s41366-018-0212-0","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"374_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/hep.25601","volume":"56","author":"CD Fuchs","year":"2012","unstructured":"Fuchs CD, Claudel T, Kumari P, Haemmerle G, Pollheimer MJ, Stojakovic T, Scharnagl H, Halilbasic E, Gumhold J, Silbert D, Koefeler H, Trauner M (2012) Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice. Hepatol 56(1):270\u2013280. https:\/\/doi.org\/10.1002\/hep.25601","journal-title":"Hepatol"},{"issue":"6","key":"374_CR11","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.21655","volume":"45","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM (2007) Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatol 45(6):1366\u20131374. https:\/\/doi.org\/10.1002\/hep.21655","journal-title":"Hepatol"},{"issue":"4","key":"374_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1586\/egh.09.32","volume":"3","author":"N Alkhouri","year":"2009","unstructured":"Alkhouri N, Dixon LJ, Feldstein AE (2009) Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev Gastroenterol Hepatol 3(4):445\u2013451. https:\/\/doi.org\/10.1586\/egh.09.32","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"374_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00535-006-1790-5","volume":"41","author":"Y Eguchi","year":"2006","unstructured":"Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, Iwakiri R, Hisatomi A, Ozaki I, Yamamoto K, Kitajima Y, Kawaguchi Y, Kuroki S, Ono N (2006) Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol 41(5):462\u2013469. https:\/\/doi.org\/10.1007\/s00535-006-1790-5","journal-title":"J Gastroenterol"},{"key":"374_CR14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.2147\/DMSO.S302297","volume":"14","author":"PJ Liu","year":"2021","unstructured":"Liu PJ, Lou HP, Zhu YN (2021) Identification of hepatic steatosis in premenopausal and postmenopausal women based on phenotypes combining triglyceride levels and anthropometric indices: a cross-sectional study. Diabetes Metab Syndr Obes 14:1339\u20131347. https:\/\/doi.org\/10.2147\/DMSO.S302297","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"374_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.rpped.2015.05.007","volume":"34","author":"AP Clemente","year":"2016","unstructured":"Clemente AP, Netto BD, de Carvalho-Ferreira JP, da Silveira Campos RM, de Piano Ganen A, Tock L, de Mello MT, Damaso AR (2016) Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents. Rev Paul Pediatr 34(1):47\u201355. https:\/\/doi.org\/10.1016\/j.rpped.2015.05.007","journal-title":"Rev Paul Pediatr"},{"issue":"10","key":"374_CR16","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.2337\/dc09-0412","volume":"32","author":"S Sam","year":"2009","unstructured":"Sam S, Haffner S, Davidson MH, D\u2019Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T (2009) Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care 32(10):1916\u20131920. https:\/\/doi.org\/10.2337\/dc09-0412","journal-title":"Diabetes Care"},{"issue":"2","key":"374_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/01.cir.102.2.179","volume":"102","author":"I Lemieux","year":"2000","unstructured":"Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud\u2019homme D, Nadeau A, Despres JP (2000) Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102(2):179\u2013184. https:\/\/doi.org\/10.1161\/01.cir.102.2.179","journal-title":"Circulation"},{"issue":"Suppl B","key":"374_CR18","doi-asserted-by":"publisher","first-page":"23B","DOI":"10.1016\/s0828-282x(07)71007-3","volume":"23","author":"I Lemieux","year":"2007","unstructured":"Lemieux I, Poirier P, Bergeron J, Almeras N, Lamarche B, Cantin B, Dagenais GR, Despres JP (2007) Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol 23(Suppl B):23B-31B. https:\/\/doi.org\/10.1016\/s0828-282x(07)71007-3","journal-title":"Can J Cardiol"},{"issue":"2","key":"374_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ijo.2010.127","volume":"35","author":"R Gomez-Huelgas","year":"2011","unstructured":"Gomez-Huelgas R, Bernal-Lopez MR, Villalobos A, Mancera-Romero J, Baca-Osorio AJ, Jansen S, Guijarro R, Salgado F, Tinahones FJ, Serrano-Rios M (2011) Hypertriglyceridemic waist: an alternative to the metabolic syndrome? Results of the IMAP Study (multidisciplinary intervention in primary care). Int J Obes (Lond) 35(2):292\u2013299. https:\/\/doi.org\/10.1038\/ijo.2010.127","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"374_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3803\/EnM.2017.32.2.221","volume":"32","author":"M Janghorbani","year":"2017","unstructured":"Janghorbani M, Salamat MR, Aminorroaya A, Amini M (2017) Utility of the visceral adiposity index and hypertriglyceridemic waist phenotype for predicting incident hypertension. Endocrinol Metab (Seoul) 32(2):221\u2013229. https:\/\/doi.org\/10.3803\/EnM.2017.32.2.221","journal-title":"Endocrinol Metab (Seoul)"},{"key":"374_CR21","doi-asserted-by":"publisher","first-page":"1031939","DOI":"10.1155\/2018\/1031939","volume":"2018","author":"K Zhao","year":"2018","unstructured":"Zhao K, Yang SS, Wang HB, Chen K, Lu ZH, Mu YM (2018) Association between the hypertriglyceridemic waist phenotype and prediabetes in Chinese adults aged 40 years and older. J Diabetes Res 2018:1031939. https:\/\/doi.org\/10.1155\/2018\/1031939","journal-title":"J Diabetes Res"},{"issue":"5","key":"374_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/jdi.12489","volume":"7","author":"Y Ren","year":"2016","unstructured":"Ren Y, Zhang M, Zhao J, Wang C, Luo X, Zhang J, Zhu T, Li X, Yin L, Pang C, Feng T, Wang B, Zhang L, Li L, Yang X, Zhang H, Hu D (2016) Association of the hypertriglyceridemic waist phenotype and type 2 diabetes mellitus among adults in China. J Diabetes Investig 7(5):689\u2013694. https:\/\/doi.org\/10.1111\/jdi.12489","journal-title":"J Diabetes Investig"},{"key":"374_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12986-020-00483-7","volume":"17","author":"Y Qiu","year":"2020","unstructured":"Qiu Y, Zhao Q, Wang N, Yu Y, Wang R, Zhang Y, Cui S, Zhu M, Liu X, Jiang Y, Zhao G (2020) Association of hypertriglyceridemic waist phenotype with renal function impairment: a cross-sectional study in a population of Chinese adults. Nutr Metab (Lond) 17:63. https:\/\/doi.org\/10.1186\/s12986-020-00483-7","journal-title":"Nutr Metab (Lond)"},{"issue":"5","key":"374_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10067-017-3559-z","volume":"36","author":"S Chen","year":"2017","unstructured":"Chen S, Guo X, Dong S, Yu S, Chen Y, Zhang N, Sun Y (2017) Association between the hypertriglyceridemic waist phenotype and hyperuricemia: a cross-sectional study. Clin Rheumatol 36(5):1111\u20131119. https:\/\/doi.org\/10.1007\/s10067-017-3559-z","journal-title":"Clin Rheumatol"},{"issue":"1","key":"374_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23(1):57\u201363. https:\/\/doi.org\/10.2337\/diacare.23.1.57","journal-title":"Diabetes Care"},{"issue":"1","key":"374_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12933-018-0692-1","volume":"17","author":"SB Lee","year":"2018","unstructured":"Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, Kim MJ, Kim MK, Park JS (2018) Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol 17(1):41. https:\/\/doi.org\/10.1186\/s12933-018-0692-1","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"374_CR27","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1210\/jc.2011-3010","volume":"97","author":"M Li","year":"2012","unstructured":"Li M, Xu Y, Xu M, Ma L, Wang T, Liu Y, Dai M, Chen Y, Lu J, Liu J, Bi Y, Ning G (2012) Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab 97(6):2033\u20132038. https:\/\/doi.org\/10.1210\/jc.2011-3010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9 Suppl","key":"374_CR28","doi-asserted-by":"publisher","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","volume":"32","author":"BE Ainsworth","year":"2000","unstructured":"Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O\u2019Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498-504. https:\/\/doi.org\/10.1097\/00005768-200009001-00009","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"374_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12944-018-0914-2","volume":"17","author":"KB Won","year":"2018","unstructured":"Won KB, Park GM, Lee SE, Cho IJ, Kim HC, Lee BK, Chang HJ (2018) Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis 17(1):268. https:\/\/doi.org\/10.1186\/s12944-018-0914-2","journal-title":"Lipids Health Dis"},{"issue":"4","key":"374_CR30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2215\/CJN.08980914","volume":"10","author":"Y Hashimoto","year":"2015","unstructured":"Hashimoto Y, Tanaka M, Okada H, Senmaru T, Hamaguchi M, Asano M, Yamazaki M, Oda Y, Hasegawa G, Toda H, Nakamura N, Fukui M (2015) Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol 10(4):578\u2013583. https:\/\/doi.org\/10.2215\/CJN.08980914","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"374_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","volume":"22","author":"GC Farrell","year":"2007","unstructured":"Farrell GC, Chitturi S, Lau GK, Sollano JD, N Asia-Pacific Working Party on (2007) Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 22(6):775\u20137. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05002.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"374_CR32","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/ijerph13040368","volume":"13","author":"S Chen","year":"2016","unstructured":"Chen S, Guo X, Yu S, Sun G, Li Z, Sun Y (2016) Association between the hypertriglyceridemic waist phenotype, prediabetes, and diabetes mellitus in rural Chinese population: a cross-sectional study. Int J Environ Res Public Health 13(4):368. https:\/\/doi.org\/10.3390\/ijerph13040368","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"374_CR33","first-page":"83","volume":"15","author":"BF Zhou","year":"2002","unstructured":"Zhou BF, C Cooperative Meta-Analysis Group of the Working Group on Obesity in (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2013study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15(1):83\u201396","journal-title":"Biomed Environ Sci"},{"issue":"9","key":"374_CR34","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/imj.14709","volume":"50","author":"TD Huang","year":"2020","unstructured":"Huang TD, Behary J, Zekry A (2020) Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern Med J 50(9):1038\u20131047. https:\/\/doi.org\/10.1111\/imj.14709","journal-title":"Intern Med J"},{"issue":"3","key":"374_CR35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.28368","volume":"63","author":"F Piscaglia","year":"2016","unstructured":"Piscaglia F, Svegliati-Baroni G, Barchetti A, Pecorelli A, Marinelli S, Tiribelli C, Bellentani S, H -N I S Group (2016) Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study. Hepatol 63(3):827\u2013838. https:\/\/doi.org\/10.1002\/hep.28368","journal-title":"Hepatol"},{"issue":"10","key":"374_CR36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.annepidem.2015.06.082","volume":"25","author":"P Du","year":"2015","unstructured":"Du P, Zhang B, Wang HJ, Qi SF, Mi YJ, Yao JC, Liu DW, Tian QB (2015) The prevalence and secular trends of abdominal obesity among Chinese adults, 1993\u20132011. Ann Epidemiol 25(10):797\u2013799. https:\/\/doi.org\/10.1016\/j.annepidem.2015.06.082","journal-title":"Ann Epidemiol"},{"issue":"1","key":"374_CR37","first-page":"113","volume":"19","author":"RF Yang","year":"2015","unstructured":"Yang RF, Liu XY, Lin Z, Zhang G (2015) Correlation study on waist circumference-triglyceride (WT) index and coronary artery scores in patients with coronary heart disease. Eur Rev Med Pharmacol Sci 19(1):113\u2013118","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"374_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3305\/nh.2014.30.1.7411","volume":"30","author":"C Cunha de Oliveira","year":"2014","unstructured":"Cunha de Oliveira C, CarneiroRoriz AK, Eickemberg M, Barreto Medeiros JM, Barbosa Ramos L (2014) Hypertriglyceridemic waist phenotype: association with metabolic disorders and visceral fat in adults. Nutr Hosp 30(1):25\u201331. https:\/\/doi.org\/10.3305\/nh.2014.30.1.7411","journal-title":"Nutr Hosp"},{"issue":"5","key":"374_CR39","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2337\/diacare.24.5.933","volume":"24","author":"DE Kelley","year":"2001","unstructured":"Kelley DE, Goodpaster BH (2001) Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24(5):933\u201341. https:\/\/doi.org\/10.2337\/diacare.24.5.933","journal-title":"Diabetes Care"},{"issue":"2","key":"374_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","volume":"23","author":"GF Lewis","year":"2002","unstructured":"Lewis GF, Carpentier A, Adeli K, Giacca A (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23(2):201\u2013229. https:\/\/doi.org\/10.1210\/edrv.23.2.0461","journal-title":"Endocr Rev"},{"issue":"5","key":"374_CR41","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2337\/diabetes.49.5.749","volume":"49","author":"L Ryysy","year":"2000","unstructured":"Ryysy L, Hakkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Jarvinen H (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49(5):749\u2013758. https:\/\/doi.org\/10.2337\/diabetes.49.5.749","journal-title":"Diabetes"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-022-00374-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T01:06:36Z","timestamp":1662944796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-022-00374-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1007\/s42000-022-00374-x","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,21]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol (No. LWEC2020024) was approved by the Ethics Committee of the Shanghai Ruijin Hospital, Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China. The subjects provided written informed consent, and the study protocol was approved by the Institute\u2019s Committee on Human Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Committee statement"}},{"value":"The study protocol (no. LWEC2020024) was approved by the Ethics Committee of the Shanghai Ruijin Hospital, Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China. The subjects gave their written informed consent; the study protocol was approved by the Institute\u2019s Committee on Human Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board statement"}},{"value":"Informed consent was obtained from all the subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}